Importance of microsatellite instability (MSI) in colorectal cancer: MSI as a daignostic tool

Annals of Oncology

Volumn 15, Issue SUPPL. 4, 2004, Pages

  Kurzawski, G ^a   Suchy, J ^a   Debniak, T ^a   Kladny J ^a   Lubinski J ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; COLON CANCER; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIAGNOSTIC VALUE; DISEASE MARKER; FAMILIAL CANCER; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; PATIENT COUNSELING; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETIC MARKERS; HUMANS; MICROSATELLITE REPEATS; PROGNOSIS; TREATMENT OUTCOME;

EID: 9744263196     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh940     Document Type: Article

References (10)

1. Shibata D, Peinado MA, Ionov Y et al. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat Genet 1994; 6: 273-281.
2. Aaltonen LA, Peltomaki P, Mecklin JP et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994; 54: 1645-1648.
3. Umar A, Boland R, Terdiman JP et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-268.
4. Suraweera N, Duval A, Reperant M et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 2002; 123: 1804-1811.
5. de Jong AE, van Puijenbroek M, Hendriks Y et al. Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 2004; 10: 972-980.
6. Kurzawski G, Safranow K, Suchy J et al. Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods 2002; 51: 89-100.
7. Gille JJ, Hogervorst FB, Pals G et al. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 2002; 87: 892-897.
8. Kładny J, Möslein G, Myrhøj T et al. Nuclear pedigree criteria of suspected HNPCC. Hereditary Cancer Clin Pract 2003; 1: 34-38.
9. PreGen-26. http:// www.exactlabs.com/pregen26/professionals/_index.htm.
10. Ribic CM, Sargent DJ, Moore MJ et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349: 247-257.